Oxford Immune Algorithmics (OIA) has developed hardware and software (Algocyte) that enables clinical blood tests to be done from home. Using a finger prick, a patient can load their blood onto a cartridge and insert it into the mobile health reader. The results are then uploaded to the cloud, where they are analyzed by OIA’s proprietary AI system, enabling the doctor to monitor the patient’s results. In the context of COVID-19, this platform is of particular importance to vulnerable patients who cannot or do not want to go to hospital.